Chris Jones is an accomplished executive and director with a strong background in the medical and biotechnology sectors. They served as CEO at GlySure Ltd and CEO at Tensys Medical from 2005 to 2008. Currently, Chris holds various leadership roles, including Chair at Verinnogen and BrIgID Bio, and Non Executive Director positions at multiple organizations, including Causeway Therapeutics and Health Enterprise East. Chris earned a B.S. in Molecular Biophysics and Biochemistry from Yale University, graduating in 1989.
Location
Oxford, United Kingdom